Search

Your search keyword '"Johnson & Johnson -- Advertising"' showing total 335 results
Start Over Descriptor "Johnson & Johnson -- Advertising"
335 results on '"Johnson & Johnson -- Advertising"'

1. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults--VISION Network, 10 States, December 2021-March 2022

Subjects
Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Vaccination, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health
Abstract

On March 29, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). CDC recommends that all persons aged [greater than or equal to] 18 [...]

Published
2022

2. Genexa, the First Clean Medicine Company, Stands Behind Its Advertising Claims and Appeals Adverse Ruling by NAD

Subjects
Johnson & Johnson -- Advertising, False advertising, General interest, News, opinion and commentary, Children's Tylenol (Medication) -- Advertising
Abstract

ATLANTA: GENEXA INC. has issued the following news release: Genexa Inc. ('Genexa'), the first ever company to make medicine with the same effective active ingredients used by big pharma--but without [...]

Published
2022

4. Community clash

Author

Dobrow, Larry

Subjects
Merck & Company Inc. -- Advertising, Allergan PLC -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Bristol-Myers Squibb Co. -- Advertising, AbbVie A/S -- Advertising, Novartis AG -- Advertising, AstraZeneca PLC -- Advertising, Eli Lilly and Co. -- Advertising, Novo Nordisk A/S -- Advertising, Television advertising, Pharmaceutical industry, Business, Health care industry, Trulicity (Medication) -- Advertising, Xeljanz (Medication) -- Advertising, Eliquis (Medication) -- Advertising, Cialis (Medication) -- Advertising, Opdivo (Medication) -- Advertising, Viagra (Medication) -- Advertising, Lyrica (Medication) -- Advertising, Breo Ellipta (Medication) -- Advertising, Chantix (Medication) -- Advertising
Abstract

Pharma spent more than $4 billion on TV ads last year. Empowered patient communities weren't impressed. Has DTC on TV reached its moment of reckoning? Let's get this out of [...]

Published
2017

5. Johnson & Johnson ordered to pay $302m over pelvic mesh implant ads; California court rules that company made misleading and potentially harmful statements in hundreds of thousands of ads

Subjects
Johnson & Johnson -- Advertising, Pharmaceutical industry, News, opinion and commentary
Abstract

Byline: Maya Yang A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay penalties to the state for deceptively marketing pelvic mesh implants for [...]

Published
2022

6. Decentralisation of creative prowess? How Mumbai is being challenged as ad capital

Subjects
Reckitt Benckiser PLC -- Advertising, Unilever N.V. -- Advertising, Johnson & Johnson -- Advertising, Procter & Gamble Co. -- Advertising, Advertising agencies, Advertising, Advertising executives, Mass communications
Abstract

Byline: Nisha Qureshi With most start-ups and a number of companies being headquartered in Delhi and Bangalore, BestMediaInfo.com decodes if Mumbai still is the advertising capital of the country For [...]

Published
2022

7. Print's charming

Author

Chase, James

Subjects
Amgen Inc. -- Advertising, Johnson & Johnson -- Advertising, Gilead Sciences Inc. -- Advertising, Pfizer Inc. -- Advertising, Boehringer Ingelheim GmbH -- Advertising, Novartis AG -- Advertising, GlaxoSmithKline PLC -- Advertising, Kantar Media -- Advertising, AstraZeneca PLC -- Advertising, Eli Lilly and Co. -- Advertising, Marketing research firms, Magazine advertising, Publishing industry, Publishing industry, Business, Health care industry, Jardiance (Medication) -- Advertising, Cometriq (Medication) -- Advertising, Eliquis (Medication) -- Advertising, Glyxambi (Medication) -- Advertising, Xgeva (Medication) -- Advertising, Neulasta (Medication) -- Advertising, Toujeo (Medication) -- Advertising, Trulicity (Medication) -- Advertising, Harvoni (Medication) -- Advertising, Humulin (Medication) -- Advertising, Vyvanse (Medication) -- Advertising, Invokana (Medication) -- Advertising, Humalog (Medication) -- Advertising, Lyrica (Medication) -- Advertising, Xarelto (Medication) -- Advertising, Keytruda (Medication) -- Advertising, Otezla (Medication) -- Advertising
Abstract

Remember all those journal-advertising obituaries that were written up a few years back in advance of the genre's supposed imminent demise? Following print's best year since 2011, it's time to [...]

Published
2016

8. Gut check: DTC is facing a new test from physicians and politicians. Here's why critics fear a deluge, and how they're pushing back

Author

Dobrow, Larry

Subjects
Merck & Company Inc. -- Advertising, Valeant Pharmaceuticals International, Inc. -- Advertising, Allergan PLC -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Bristol-Myers Squibb Co. -- Advertising, AbbVie L.L.C. -- Advertising, GlaxoSmithKline PLC -- Advertising, AstraZeneca PLC -- Advertising, Eli Lilly and Co. -- Advertising, Advertising, Medical societies, Drugs -- Planning, Company business planning, Business, Health care industry, Xeljanz (Medication) -- Advertising, Harvoni (Medication) -- Advertising, Cialis (Medication) -- Advertising, Eliquis (Medication) -- Advertising, Invokana (Medication) -- Advertising, Viagra (Medication) -- Advertising, Opdivo (Medication) -- Advertising, Lyrica (Medication) -- Advertising, Latuda (Medication) -- Advertising
Abstract

Last November, when many of the world's most engaged physicians convened at an interim meeting of the American Medical Association, they expected little of major consequence to transpire. Within the [...]

Published
2016

9. DTC unbound

Subjects
Merck & Company Inc. -- Advertising, Allergan PLC -- Advertising, Amgen Inc. -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Bristol-Myers Squibb Co. -- Advertising, AbbVie Corp. -- Advertising, AstraZeneca PLC -- Advertising, Eli Lilly and Co. -- Advertising, Sumitomo Pharmaceuticals Company Ltd. -- Advertising, Print advertising, Business, Health care industry, Xeljanz (Medication) -- Advertising, Abilify (Medication) -- Advertising, Cialis (Medication) -- Advertising, Eliquis (Medication) -- Advertising, Viagra (Medication) -- Advertising, Humira (Medication) -- Advertising, Latuda (Medication) -- Advertising, Lyrica (Medication) -- Advertising, Celebrex (Medication) -- Advertising, Chantix (Medication) -- Advertising
Abstract

DTC pharma advertising works--ask anyone. But over the years, its effectiveness has been blunted by FDA requirements that, marketers claim, befog rather than clarify. Larry Dobrow surveys the DTC landscape [...]

Published
2015

10. Back in the mix

Author

Chase, James

Subjects
Amgen Inc. -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Gilead Sciences Inc. -- Advertising, Roche A/S -- Advertising, Novartis AG -- Advertising, Takeda U.S.A. Inc. -- Advertising, GlaxoSmithKline PLC -- Advertising, AstraZeneca PLC -- Advertising, Print advertising, Publishing industry, Publishing industry, Business, Health care industry, Jardiance (Medication) -- Advertising, Abilify (Medication) -- Advertising, Tecfidera (Medication) -- Advertising, Belvig (Medication) -- Advertising, Eliquis (Medication) -- Advertising, Brintellix (Medication) -- Advertising, Nuvigil (Medication) -- Advertising, Anoro ellipta (Medication) -- Advertising, Xgeva (Medication) -- Advertising, Symbicort (Medication) -- Advertising, Sovaldi (Medication) -- Advertising, Xerese (Medication) -- Advertising, Enbrel (Medication) -- Advertising, Fetzima (Medication) -- Advertising, Invokana (Medication) -- Advertising, Welchol (Medication) -- Advertising, Invokamet (Medication) -- Advertising, Latuda (Medication) -- Advertising, Lyrica (Medication) -- Advertising, Xarelto (Medication) -- Advertising, Otezla (Medication) -- Advertising, Belviq (Medication) -- Advertising
Abstract

A few years ago medical publishers were approaching a cliff and the choices were simple: Evolve the business or fall over the edge. By having learned to survive, some publishers [...]

Published
2015

11. 2014 Judges

Subjects
Merck & Company Inc. -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Bristol-Myers Squibb Co. -- Advertising, Sudler & Hennessey L.L.C. -- Advertising, Novartis AG -- Advertising, Eisai Inc. -- Advertising, AstraZeneca PLC -- Advertising, Advertising agencies, Financial services industry, Pharmaceutical industry, Financial services industry, Business, Health care industry
Abstract

The Award Picking the best from a stellar crop of submissions is a challeging job. Our panel of more than 100 of the industry's top thinkers, opinion makers and creatives [...]

Published
2014

12. Biden Focuses On Personal Healthcare Experiences In New T.V. Ad; Puerto Rico Under Hurricane Watch And Tropical Storm Warning; Landmark Opioid Judgment Could Pave Way In Fight Against Crisis. Aired 10-10:30a ET

Subjects
Johnson & Johnson -- Advertising, Pharmaceutical industry, News, opinion and commentary, Patient Protection and Affordable Care Act
Abstract

(COMMERCIAL BREAK) [10:00:00] JIM SCIUTTO, CNN NEWSROOM: A good morning. I'm Jim Sciutto in Washington. Poppy Harlow is off today. Joe Biden opens up while his 2020 foes appear at [...]

Published
2019

13. Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio

Author

Bulik, Beth Snyder

Subjects
Johnson & Johnson -- Advertising, Eli Lilly and Co. -- Advertising, Endorsement advertising, Diabetes therapy, Sports sponsorship, Drugs, Athletes, Type 2 diabetes, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Trulicity (Medication) -- Advertising, Verzenio (Medication) -- Advertising, Emgality (Medication) -- Advertising
Abstract

Byline: Beth Snyder Bulik While the Summer Olympics don't start until later this month, Eli Lilly and its Team USA athletes are already taking on health conditions in ads and [...]

Published
2021

14. J&J opts for bolder, darker tone in new Tremfya ads to reflect real-life patient struggles

Author

Coey, Sharon Klahr

Subjects
Johnson & Johnson -- Advertising, Eli Lilly and Co. -- Advertising, Psoriasis, Arthritis, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Tremfya (Medication) -- Advertising
Abstract

Byline: Sharon Klahr Coey Johnson & Johnson is changing up the look and tone for psoriasis med Tremfya's advertising to reflect patients' real-life experiences. The more somber, darkly lit TV [...]

Published
2021

15. GSK ViiV's Dovato squares off against Evofem's Phexxi in final #FierceMadness DTC ad matchup

Author

Bulik, Beth Snyder

Subjects
Johnson & Johnson -- Advertising, Vaccines, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Dovato (Medication) -- Advertising, Phexxi (Contraceptive) -- Advertising
Abstract

Byline: Beth Snyder Bulik The final showdown is set in the FierceMadness DTC ad contest. Dovato from GlaxoSmithKline's ViiV Healthcare will go up against Phexxi from Evofem Biosciences for the [...]

Published
2021

16. #FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the Elite Eight still standing

Author

Bulik, Beth Snyder

Subjects
Bayer AG -- Advertising, Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Novartis AG -- Advertising, Advertising campaigns, Contests, Advertising executives, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Dovato (Medication) -- Advertising, Phexxi (Contraceptive) -- Advertising
Abstract

Byline: Beth Snyder Bulik FierceMadess voters have spoken--and now, just an Elite Eight pharma advertisers are still in the running for the 2021 title. Pfizer, Bayer, Novartis, Roche, Johnson & [...]

Published
2021

17. Bayer, Roche, Novo Nordisk, J&J, Novartis and Gilead among the Sweet 16 advancing in #FierceMadness DTC ad tourney

Author

Bulik, Beth Snyder

Subjects
Johnson & Johnson -- Advertising, Bayer AG -- Advertising, Pfizer Inc. -- Advertising, Novartis AG -- Advertising, Novo Nordisk A/S -- Advertising, Advertising executives, Vaccines, Type 2 diabetes, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Nurtec (Medication) -- Advertising, Ocrevus (Medication) -- Advertising, Phexxi (Contraceptive) -- Advertising
Abstract

Byline: Beth Snyder Bulik The #FierceMadness DTC ad tournament is down to the Sweet 16. And just like this weekend's NCAA March Madness surprises--Ohio State knocked out by Oral Roberts [...]

Published
2021

18. Manufacturers knock drug pricing bill in ads

Author

Evers-Hillstrom, Karl

Subjects
Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Americans -- Political activity -- Political aspects, Drugs -- Political aspects, Pharmaceutical industry -- Political aspects -- Political activity, Pharmaceutical policy -- Political aspects, Political science
Abstract

* The National Association of Manufacturers launched a six-figure ad campaign over the weekend opposing Democrats' proposal to regulate drug prices in their budget reconciliation package. The lobbying group, which [...]

Published
2022

19. FACEBOOK TO BAN ANTI-VACCINE ADS

Subjects
United States. International Broadcasting Bureau. Voice of America, Johnson & Johnson -- Advertising, Influenza vaccines, Vaccination, Pharmaceutical industry, COVID-19, News, opinion and commentary, Facebook (Online social network) -- Advertising
Abstract

WASHINGTON, DC -- The following information was released by the Voice of America (VOA): Facebook says it will block ads that discourage people from getting vaccinated, including flu shots and [...]

Published
2020

20. JWT saga is raising wider questions for the industry

Subjects
Johnson & Johnson -- Advertising, Advertising agencies, Advertising executives, Pharmaceutical industry, Advertising, marketing and public relations, Business, Business, international, Mass communications
Abstract

I was in Campaign's US headquarters in the fashion district of Manhattan last week when the New York Post published a story headlined: 'JWT CEO made rape jokes, mocked Jews [...]

Published
2016

21. CQ News

Subjects
Johnson & Johnson -- Advertising, Medical societies, Chambers of commerce, Pharmaceutical industry, Prescriptions (Drugs), Law, Xarelto (Medication) -- Advertising
Abstract

Doctors and the pharmaceutical industry want more scrutiny of advertisements for lawsuits relating to prescription drugs, and are getting backing from the powerful U.S. Chamber of Commerce and the chairman [...]

Published
2017

22. PFIZER BANS FORCED SWIM TEST AFTER PETA CAMPAIGN

Subjects
Johnson & Johnson -- Advertising, Pfizer Inc. -- Advertising, Evidence-based medicine, Pharmaceutical industry, Stockholders, Advertising executives, Television advertising, News, opinion and commentary
Abstract

SHORT HILLS, N.J. -- The following information was released by People for the Ethical Treatment of Animals (PETA): Pharma Giant Joins Johnson and Johnson, Roche, and Others in Saying No [...]

Published
2019

23. NAD Recommends Bayer Discontinue Comparative Superiority Claims for Aleve Following Johnson & Johnson Challenge; Advertiser to Appeal

Subjects
Johnson & Johnson -- Advertising, Bayer HealthCare L.L.C. -- Advertising, Advertising -- Comparative analysis, Industry self regulation -- Comparative analysis, Acetaminophen -- Comparative analysis, Pharmaceutical industry -- Comparative analysis, Industry regulations, National advertising, General interest, News, opinion and commentary, Aleve (Medication) -- Advertising -- Comparative analysis
Abstract

New York: Advertising Self-Regulatory Council has issued the following press release: The National Advertising Division has recommended that Bayer Healthcare LLC discontinue the claims 'Proven Better on Pain than Tylenol [...]

Published
2019

24. Johnson & Johnson to provide price of popular drug in TV ads

Subjects
Cable News Network -- Advertising, Johnson & Johnson -- Advertising, Cable television broadcasting industry, Pharmaceutical industry, Drugs, Prescriptions (Drugs), Television advertising, Advertising executives, Competition (Economics), General interest, News, opinion and commentary, Xarelto (Medication) -- Advertising
Abstract

Byline: Tami Luhby, CNN(CNN) -- Johnson & Johnson will become the first drug maker to include the price of a prescription drug in TV ads.The pharmaceutical titan will provide both [...]

Published
2019

25. Of Diabetes, ONETOUCH & Khud ki care

Subjects
Johnson & Johnson -- Advertising, Diabetes mellitus, Advertising campaigns, Diabetes therapy, Pharmaceutical industry, Advertising, marketing and public relations
Abstract

ONETOUCH launched a single ad campaign with Boman Irani and Simone Singh in the month of March. The gentle banter between the husband and wife captured the consumers' imagination and [...]

Published
2015

26. We invest a lot in creating patient awareness: Amit Raheja

Subjects
Johnson & Johnson -- Advertising, Diabetes mellitus, Advertising campaigns, Diabetes therapy, Pharmaceutical industry, Advertising, marketing and public relations
Abstract

ONETOUCH launched a single ad campaign with Boman Irani and Simone Singh in the month of March. The gentle banter between the husband and wife captured the consumers' imagination and [...]

Published
2015

27. Media: Digital advertising needs to confront issues of trust

Subjects
Johnson & Johnson -- Advertising, L'Oreal S.A. -- Advertising, Coca-Cola Co. (Atlanta, Georgia) -- Advertising, Procter & Gamble Co. -- Advertising, Volkswagen AG -- Advertising, Automobile industry, Soft drink industry, Advertising, Soap and cleaning agents industry, Cosmetics industry, Pharmaceutical industry, Automobile Industry, Advertising, marketing and public relations, Business, Business, international, Mass communications
Abstract

It was not long before talk in Cannes last week turned to the small matter of the dollars 25 billion media business up for grabs in a series of global [...]

Published
2015

28. Pitch update

Subjects
Johnson & Johnson -- Advertising, Pharmaceutical industry, Advertising, marketing and public relations, Business, Business, international, Mass communications
Abstract

Johnson & Johnson has called a global review of its media planning and buying across its consumer, pharmaceutical and medical device businesses and brands. The review will not include North [...]

Published
2015

29. Patient empowerment or Pandora's box? Can Big Pharma regain consumer confidence with new, more candid drug ads?

Author

Wilkie, Dana

Subjects
United States. Food and Drug Administration, Johnson & Johnson -- Advertising, Consumer confidence, Television advertising, Physician and patient, Pharmaceutical industry, Biological sciences
Abstract

This spring, Johnson & Johnson began airing new ads for its birth control patch, and viewers may have noticed that the message was significantly more sobering than in past ads. [...]

Published
2005

30. Google's bad week: YouTube loses millions as advertising row reaches US; Major brands including Verizon and Walmart pulled their ads after they were found to be appearing next to videos promoting extremist views or hate speech

Subjects
Coffeehouses, Discount stores, Advertising, Telecommunications services industry, Pharmaceutical industry, Communications industry, Telecommunications services industry, Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Starbucks Corp. -- Advertising, Walmart Inc. -- Advertising
Published
2017

31. UK: Johnson & Johnson pulled up over UK Benecol ad

Subjects
Johnson & Johnson -- Advertising, Blood cholesterol, Pharmaceutical industry, Business, Food and beverage industries
Abstract

Byline: Hannah Abdulla Johnson & Johnson has said it is 'disappointed' at UK advertising ruling that said the healthcare giant had 'exaggerated' the health benefits of Benecol. The UK's Advertising [...]

Published
2014

32. Advert claim is sticking point

Subjects
Johnson & Johnson -- Advertising, Advertising, Pharmaceutical industry, Business, Health care industry, Business, international
Abstract

Johnson & Johnson Vision Care (JJVC) has disagreed with a finding by US advertising body the National Advertising Division (NAD) that it had used a leading study question to form [...]

Published
2014

33. A recent ad for Johnson`s Baby Wash is cleaning up online

Subjects
Johnson & Johnson -- Advertising, Baby products -- Advertising, Pharmaceutical industry -- Advertising, General interest, News, opinion and commentary
Abstract

VINITA NAIR: A recent ad for Johnson`s Baby Wash is cleaning up online. It has nearly two million views on YouTube. Gayle King couldn`t wait to see the baby`s smiling [...]

Published
2015

34. That`s part of a commercial advertiser would consider a huge home run

Subjects
Johnson & Johnson -- Advertising, Infants -- Appreciation, Baby products -- Advertising, Pharmaceutical industry -- Advertising, General interest, News, opinion and commentary
Abstract

GAYLE KING: That`s part of a commercial advertiser would consider a huge home run. The recent spot for Johnson`s baby wash is making a huge splash with more than one [...]

Published
2015

35. As seen on television: Advertisement for EPO

Author

Wyatt, Edward

Subjects
Johnson & Johnson -- Advertising, Procrit (Medication) -- Advertising, Drugs and athletes -- Analysis, Cyclists -- Laws, regulations and rules, Steroids (Drugs) -- Advertising
Published
2002

36. Reining in direct-to-customer advertising

Subjects
Vioxx (Medication) -- Advertising, Bextra (Medication) -- Advertising, Pharmaceutical industry -- Advertising, Johnson & Johnson -- Advertising
Published
2005

37. Tylenol back on air after recall rough patch

Subjects
Tylenol (Medication) -- Advertising, Analgesics -- Advertising, Pharmaceutical industry -- Advertising, Johnson & Johnson -- Advertising
Abstract

After multiple recalls, an overhaul of factories and a shortage of product, Johnson & Johnson's Tylenol brand returned to the airwaves last week. The ad, which likely marks the start [...]

Published
2013

38. J&J gets emotional in corporate-branding campaign

Subjects
Pharmaceutical industry -- Advertising, Johnson & Johnson -- Advertising
Abstract

Beleaguered by lawsuits and battered by recalls, Johnson & Johnson is hoping that softly shot advertising will soothe consumers. Last week, the company unveiled a corporate branding campaign called "For [...]

Published
2013

39. Another talc cancer trial starts in St. Louis

Subjects
Johnson & Johnson -- Advertising, False advertising -- Health aspects, Cancer -- Health aspects, Pharmaceutical industry -- Health aspects, Ovarian cancer -- Health aspects, News, opinion and commentary, Business, regional
Abstract

Byline: Catherine Martin After more than a week of jury selection, a trial against Johnson & Johnson alleging the company's talcum powder caused ovarian cancer got underway in St. Louis [...]

Published
2016

40. Publicis' digital focus key to LBi deal

Subjects
Johnson & Johnson -- Advertising, Coca-Cola Co. (Atlanta, Georgia) -- Advertising, Advertising agencies, Soft drink industry, Pharmaceutical industry, Advertising, marketing and public relations, Business, Business, international, Mass communications
Abstract

Luke Taylor, the chief executive of LBi, explains why his digital agency network agreed to sell to Publicis Groupe for pounds 333m. Last Thursday, Publicis Groupe announced a pounds 333 [...]

Published
2012

41. Google Set to Take Hit in Data War with Cable and Telecoms

Subjects
United States. Federal Communications Commission, Verizon Communications Inc. -- Advertising, Comcast Corp. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Charter Communications Inc. -- Advertising, Cable television broadcasting industry, Advertising, Telecommunications services industry, Communications industry, Pharmaceutical industry, Telecommunications services industry, Business, Facebook (Online social network) -- Advertising
Abstract

Byline: Chris Nolter To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/story/14064557/1/google-set-to-take-hit-in-data-war-with-cable-and-telecoms.html The battle over internet privacy and the concurrent advertiser backlash [...]

Published
2017

42. Holden and Kia pull ads from YouTube

Subjects
Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Kia Corp. -- Advertising, Walmart Inc. -- Advertising, Discount stores, Automobile industry, Telecommunications services industry, Communications industry, Pharmaceutical industry, Telecommunications services industry, Automobile Industry, Business, Business, international
Abstract

Byline: Max Mason Mar 26, 2017 (The Australian Financial Review - ABIX via COMTEX) -- GM Holden and Kia Motors are the latest companies to boycott advertising on Google-owned websites [...]

Published
2017

43. Google's Ad Controversy Is a 'Temporary Issue' With Limited Financial Impact, Analyst Says

Subjects
Verizon Communications Inc. -- Advertising, JPMorgan Chase & Co. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Banking industry, Pharmaceutical industry, Telecommunications industry, Telecommunications services industry, Banking industry, Business
Abstract

Byline: Annie Palmer To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/story/14058767/1/google-s-ad-controversy-is-a-temporary-issue-with-limited-financial-impact-analyst-says.html A growing list of advertisers have decided to scale back [...]

Published
2017

44. AT&T and Verizon pull ads from Google

Subjects
Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Pharmaceutical industry, Telecommunications industry, Telecommunications services industry, Business, Business, international
Abstract

Byline: Mark Bergen and Joe Mayes Mar 23, 2017 (The Australian Financial Review - ABIX via COMTEX) -- A growing number of companies are joining the boycott of Google's display [...]

Published
2017

45. Why Google Needs to Forcefully Address Its Video Ad Problem

Subjects
Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Advertising, Health care industry, Pharmaceutical industry, Telecommunications industry, Health care industry, Telecommunications services industry, Business
Abstract

Byline: Annie Palmer To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/story/14057812/1/why-google-needs-to-forcefully-address-its-video-ad-problem.html To many analysts and investors, it seemed that Alphabet's (GOOGL) [...]

Published
2017

46. Johnson & Johnson Latest to Pull Ads From YouTube

Subjects
Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Pharmaceutical industry, Telecommunications industry, Antisemitism, Telecommunications services industry, Business
Abstract

Byline: Giovanni Bruno To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/story/14057664/1/johnson-amp-johnson-latest-to-pull-ads-from-youtube.html Johnson & Johnson (JNJ) on Thursday suspended all digital advertising [...]

Published
2017

47. J&J pulls ads from YouTube over 'offensive' videos

Subjects
Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Pharmaceutical industry, Advertising executives, Telecommunications industry, Telecommunications services industry, General interest, News, opinion and commentary
Abstract

US healthcare conglomerate Johnson & Johnson has become the latest company to suspend all digital advertising on YouTube over concerns its ads may have appeared on channels that broadcast offensive [...]

Published
2017

48. AT&T and Verizon halt Google ads over extremist videos

Subjects
Cable television broadcasting industry, Telecommunications services industry, Advertising executives, Video production companies, Communications industry, Pharmaceutical industry, Telecommunications services industry, Verizon Communications Inc. -- Advertising, Johnson & Johnson -- Advertising, AT&T Inc. -- Advertising, Warner Media L.L.C. -- Advertising, Cable News Network -- Advertising
Published
2017

49. The Week: Advertising Reviews - JWT wins J&J World Cup task

Subjects
Johnson & Johnson -- Advertising, Ogilvy & Mather Worldwide Inc. -- Advertising, Advertising agencies -- 2014 AD, Advertising -- 2014 AD, Pharmaceutical industry -- 2014 AD, Advertising, marketing and public relations, Business, Business, international, Mass communications
Abstract

Johnson & Johnson has appointed JWT to handle the advertising to promote its sponsorship of the 2014 Fifa World Cup in Brazil. The agency beat the fellow Johnson & Johnson [...]

Published
2011

50. Benadryl uses pollen count to target ads on Weather Channel

Author

Lovett, Gina

Subjects
Johnson & Johnson -- Advertising, The Weather Channel Inc. -- Advertising, Cable television broadcasting industry, Pharmaceutical industry, Advertising, marketing and public relations, Mass communications, Benadryl (Medication) -- Advertising
Abstract

Byline: Gina Lovett Benadryl has launched a six-figure seasonal display campaign across The Weather Channel's UK website and iPhone app, its first cross-platform deal in the UK. The Johnson & [...]

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results